PBA
Paradigm Biocapital Advisors’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28M | Sell |
1,870,445
-256,760
| -12% | -$3.84M | 1.2% | 23 |
|
|
2025
Q1 | $34.3M | Buy |
2,127,205
+600,000
| +39% | +$9.68M | 1.57% | 18 |
|
|
2024
Q4 | $35.6M | Buy |
1,527,205
+259,624
| +20% | +$6.04M | 1.24% | 20 |
|
|
2024
Q3 | $37.3M | Buy |
+1,267,581
| New | +$37.3M | 1.26% | 25 |
|